Whether cannabis is used in a medical or recreational context, doing so in the safest manner possible is paramount.  While there is good evidence that smoking cannabis is less risky than tobacco (1), it likely still poses some risk.

On March 26, the Association of Cannabinoid Specialists (www.cannaspecialists.com) hosted an event in conjunction with the University of Maryland School of Pharmacy.  The event was career focused and used an Ask Us Anything template with questions submitted by students prior to the event.

The human body is a complex network of interacting systems, each with its own set of responsibilities. Among these intricate systems is the endocannabinoid system (ECS), a fascinating and relatively recent discovery in the field of neuroscience.

Recently, the Delaware House of Representatives, following ideas from Washington D.C., passed a law to do two things:  (1) remove the list of qualifying conditions from their medical cannabis laws, and (2) allow people over the age of 65 to “self-certify” that they need marijuana for medical purposes.

Dear Madam/Sir: I write to you to support the petitions before you to include anxiety, depression, and insomnia as qualifying conditions for medical cannabis treatment in Hawai’i.

The Association of Cannabinoid Specialists will be active at the American Academy of Pain Medicine's 40th Annual Meeting in Scottsdale, AZ from March 7-10, 2024.  Come talk to us, learn from us, and join us as we work toward making cannabis a mainstream pain management option.

This week there has been a flurry of discussion about cannabis’ harmful effects on the heart.  I have received numerous anxiety-ridden emails from colleagues, patients, and my mother (she’s not on cannabis, go figure).  This all stems from a recently published scientific paper in the Journal of the American Heart Association. (1)

Q: Tell us a little bit about yourself.

A: My name is Sandra Carrillo, and I am a medical doctor. I have had a clinical practice in Colombia for several years.  I am a specialist in cannabinoid-based medicine.

Dear Members of the Joint Committee:

As one of the senior cannabis physicians in the Commonwealth of Massachusetts, President of the Association of Cannabis Specialists, Board Member of the Massachusetts Patient Advocacy Alliance, and former VA physician I wish to convey some very specific concerns regarding House Bill 4274. Despite vocal advocacy by a few veterans, this bill is not in the interests of veterans or other patients.